Mesenchymal stromal cells: a novel therapy for the treatment of chronic obstructive pulmonary disease?

@inproceedings{Broekman2018MesenchymalSC,
  title={Mesenchymal stromal cells: a novel therapy for the treatment of chronic obstructive pulmonary disease?},
  author={Winifred Broekman and P. Padmini S. J. Khedoe and K. Schepers and Helene Roelofs and J. G. Stolk and Pieter S Hiemstra},
  booktitle={Thorax},
  year={2018}
}
COPD is characterised by tissue destruction and inflammation. Given the lack of curative treatments and the progressive nature of the disease, new treatments for COPD are highly relevant. In vitro cell culture and animal studies have demonstrated that mesenchymal stromal cells (MSCs) have the capacity to modify immune responses and to enhance tissue repair. These properties of MSCs provided a rationale to investigate their potential for treatment of a variety of diseases, including COPD… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 19 times over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 92 references

Acute and chronic effects of treatment with mesenchymal stromal cells on LPS-induced pulmonary inflammation, emphysema and atherosclerosis development

  • P Khedoe, S de Kleijn, AM van Oeveren-Rietdijk
  • PLoS One 2017;12:e0183741
  • 2017

Similar Papers

Loading similar papers…